TRIAL OF NUTRAMIGEN VS A MODIFIED CASEIN HYDROLYSATE FORMULA

NUTRAMIGEN 与改良酪蛋白水解物配方的对比试验

• 批准号: 3784639
• 负责人: HUGH A SAMPSON
• 金额: --
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3784639
• 关键词: caseins; child (0-11); clinical trials; developmental nutrition; diet therapy; food hypersensitivity; food quality /standard; gastrointestinal sign /symptom; human subject; human therapy evaluation; milk; nutrition related tag; placebos; respiratory hypersensitivity; skin hypersensitivity

The purpose of this multicenter trial was to compare the safety of a new casein hydrolysate formulation of Nutramigen to standard Nutramigen in children with cow's milk allergy (CMA). Preliminary laboratory studies suggested it should be safe in CMA children. However, 2 of 20 CMA children experienced cutaneous, respiratory and/or milk abdominal symptoms after ingesting the formula in a double-blind trial.

这项多中心试验的目的是比较一种新的 Nutramigen与标准Nutramigen的酪蛋白水解产物制剂 牛奶过敏（CMA） 初步实验室研究 建议它应该是安全的CMA儿童。 20个CMA中有2个 儿童出现皮肤、呼吸道和/或乳腹部 在一项双盲试验中，